Paeds Cases · endocrinology-diabetes-and-growth
Communicating a new Graves disease diagnosis — OSCE
OSCE communication and shared decision-making station: explaining to a thirteen-year-old girl and her mother what a new Graves disease diagnosis means, how the antibody caused the palpitations, weight loss, tremor, anxiety and eye changes, what the immediate and long-term plan is (a beta-blocker for symptoms, carbimazole first-line with the two drug dangers warned about, the two-to-three-year course and the relapse reality), what the definitive options are if the drugs do not hold, and how the school, growth and transition will be supported — while addressing fear, the burden of a years-long regimen, the cosmetic worry about the eyes, and the search for a cure.
On this page
Study tools
Target exams
Task
Counsel the girl and her mother. You have five minutes. Demonstrate an organised, empathic and accurate explanation that addresses the four questions a fellowship communication station rewards: what is happening to her body and why, what the immediate and long-term plan is, what the outlook and the options are if the tablets do not hold, and how her school, growth and future will be supported. The management framework follows the 2016 American Thyroid Association hyperthyroidism guidelines. [1]
References4ShowHide
- [1]Ross DS, Burch HB, Cooper DS, Greenlee MC, Laurberg P, Maia AL, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid, 2016.PMID 27521067
- [6]Léger J, Carel JC. MANAGEMENT OF ENDOCRINE DISEASE: Arguments for the prolonged use of antithyroid drugs in children with Graves' disease. Eur J Endocrinol, 2017.PMID 28381452
- [9]Rivkees SA, Mattison DR. Propylthiouracil (PTU) Hepatoxicity in Children and Recommendations for Discontinuation of Use. Int J Pediatr Endocrinol, 2009.PMID 19946400
- [10]Bahn RS. Graves' ophthalmopathy. N Engl J Med, 2010.PMID 20181974